Wenshen Jianpi Recipe Induced Immune Reconstruction and Redistribution of Natural Killer Cell Subsets in Immunological Non-responders of Human Immunodeficiency Virus/acquired Immune Deficiency Syndrome: a Randomized Controlled Trial

Overview

Journal J Tradit Chin Med

Date 2022 Sep 9

PMID 36083488

Authors

Tao Zhuang

Wang Jian

Chen Xin

L I Yonghong

Yan Yuguang

Zhang Ao

Zou Wen

Liu Ying

Affiliations

Soon will be listed here.

Abstract

Objective: To evaluate the effects of the Wenshen Jianpi recipe (, WJR) on immune reconstruction and natural killer (NK) cells in immunological non-responders (INRs) of people living with human immunodeficiency virus (HIV) (PLWH) and propose new therapeutic strategies for HIV.

Methods: Based on Traditional Chinese Medicine treatment principle "invigorating and warming in the spleen and kidneys", WJR combined with antire-troviral therapy (ART) therapy was performed in a randomized, double-blind, placebo-controlled study of 60 patients with non-responders. The randomized process was executed by the Clinical Evaluation Center of China Academy of Chinese Medical Sciences. Sixty patients who met the inclusion criteria obtained random numbers (that is the drug number) was randomly divided into a treatment group and a placebo control group according to a 1∶1 ratio. CD4+T cell counts and natural killer (NK) cells counts were evaluated at baseline and 12-week, 24-week follow-ups.

Results: Four participants received random numbers and did not enter the group due to the patient's own reasons. A total of 56 patients were enrolled, including 28 in the treatment group and 28 in the control group. CD4+T cell counts in the treatment group were significantly increased at week 24 ( = 0.01 < 0.05), which were significantly higher than those in the control group (= 0.01 < 0.05). Although no significant differences were observed between two groups, the CD56briCD16- NK cell counts in the treatment group were significantly increased after duration. and CD56dimCD16+ NK cell counts in the treatment group were significantly higher than those in the control group after 24 weeks of treatment (= 0.025 < 0.05). As compared with the control group, the treatment group had significantly lower CD56negCD16+ NK cell counts after 24 weeks of treatment (= 0.023 < 0.05).

Conclusions: WJR promotes the immune reconstruction of INRs and redistribution of NK cell subsets, notably decreasing CD56negCD16+ NK cell counts in INRs. However, the redistribution of NK cell subsets is not beneficial for immune reconstruction in INRs. Further large-scale RCTs are required to evaluate the effect of WJR on immune recovery in INRs and decipher the underlying mechanism.

Citing Articles

Anti-HIV activity in traditional Chinese medicine: clinical implications of monomeric herbal remedies and compound decoctions.

Zhang N, Wang M, Gao L, Zhang C, Tang X, Liu X Front Med (Lausanne). 2024; 11:1322870.

PMID: 39175814 PMC: 11340536. DOI: 10.3389/fmed.2024.1322870.

References

Kuri-Cervantes L, Salgado-Montes de Oca G, Avila-Rios S, Hernandez-Juan R, Reyes-Teran G . Activation of NK cells is associated with HIV-1 disease progression. J Leukoc Biol. 2014; 96(1):7-16. DOI: 10.1189/jlb.0913514. View

Fauci A, Lane H . Four Decades of HIV/AIDS - Much Accomplished, Much to Do. N Engl J Med. 2020; 383(1):1-4. DOI: 10.1056/NEJMp1916753. View

Rydyznski C, Daniels K, Karmele E, Brooks T, Mahl S, Moran M . Generation of cellular immune memory and B-cell immunity is impaired by natural killer cells. Nat Commun. 2015; 6:6375. PMC: 4346304. DOI: 10.1038/ncomms7375. View

Lichtfuss G, Cheng W, Farsakoglu Y, Paukovics G, Rajasuriar R, Velayudham P . Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation. J Immunol. 2012; 189(3):1491-9. DOI: 10.4049/jimmunol.1200458. View

Milush J, Lopez-Verges S, York V, Deeks S, Martin J, Hecht F . CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology. 2013; 10:158. PMC: 3892122. DOI: 10.1186/1742-4690-10-158. View

Esposito F, Carli I, Del Vecchio C, Xu L, Corona A, Grandi N . Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication. Phytomedicine. 2016; 23(12):1383-1391. DOI: 10.1016/j.phymed.2016.08.001. View

Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2011; 9(8):672-7. DOI: 10.1016/j.ijsu.2011.09.004. View

Luo Z, Li Z, Martin L, Hu Z, Wu H, Wan Z . Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression. PLoS One. 2017; 12(1):e0167640. PMC: 5226712. DOI: 10.1371/journal.pone.0167640. View

Florez-Alvarez L, Hernandez J, Zapata W . NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies. Front Immunol. 2018; 9:2290. PMC: 6199347. DOI: 10.3389/fimmu.2018.02290. View

10.

Xu J, Zhang J, Wang J . The Application of Traditional Chinese Medicine Against the Tumor Immune Escape. J Transl Int Med. 2021; 8(4):203-204. PMC: 7805287. DOI: 10.2478/jtim-2020-0032. View

11.

Asher I, Guri K, Elbirt D, Rosenberg Bezalel S, Maldarelli F, Mor O . Characteristics and Outcome of Patients Diagnosed With HIV at Older Age. Medicine (Baltimore). 2016; 95(1):e2327. PMC: 4706254. DOI: 10.1097/MD.0000000000002327. View

12.

Xu L, Grandi N, Del Vecchio C, Mandas D, Corona A, Piano D . From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. J Microbiol. 2015; 53(4):288-93. DOI: 10.1007/s12275-015-4652-0. View

13.

Sun W, Liu Y, Zhou W, Li H, Yang J, Chen Z . Shikonin inhibits TNF-α production through suppressing PKC-NF-κB-dependent decrease of IL-10 in rheumatoid arthritis-like cell model. J Nat Med. 2016; 71(2):349-356. DOI: 10.1007/s11418-016-1064-3. View

14.

Quillay H, El Costa H, Duriez M, Marlin R, Cannou C, Madec Y . NK cells control HIV-1 infection of macrophages through soluble factors and cellular contacts in the human decidua. Retrovirology. 2016; 13(1):39. PMC: 4895978. DOI: 10.1186/s12977-016-0271-z. View

15.

Jiang Y, Yang M, Sun X, Chen X, Ma M, Yin X . IL-10 NK and TGF-β NK cells play negative regulatory roles in HIV infection. BMC Infect Dis. 2018; 18(1):80. PMC: 5812185. DOI: 10.1186/s12879-018-2991-2. View

16.

Tao Z, Huang X, Liu Y, Wang R, Dong J, Liang B . Efficacy of integrated Traditional Chinese Medicine and anti-retroviral therapy on immunological nonresponse in patients with human immunodeficiency virus/acquired immunodeficiency syndrome: a Meta-analysis of randomized controlled trial. J Tradit Chin Med. 2021; 41(5):669-676. DOI: 10.19852/j.cnki.jtcm.2021.05.002. View

17.

Altfeld M, Fadda L, Frleta D, Bhardwaj N . DCs and NK cells: critical effectors in the immune response to HIV-1. Nat Rev Immunol. 2011; 11(3):176-86. PMC: 3278081. DOI: 10.1038/nri2935. View

18.

Quaranta M, Napolitano A, Sanchez M, Giordani L, Mattioli B, Viora M . HIV-1 Nef impairs the dynamic of DC/NK crosstalk: different outcome of CD56(dim) and CD56(bright) NK cell subsets. FASEB J. 2007; 21(10):2323-34. DOI: 10.1096/fj.06-7883com. View

19.

Zhou Z, Liu X, Wu T, Que Z, Wu Z, Wu W . Herbal formula of Bushen Jianpi combined with sorafenib inhibits hepatocellular carcinoma growth by promoting cell apoptosis and blocking the cell cycle. J Tradit Chin Med. 2021; 41(2):194-202. View

20.

Tarazona R, G Casado J, DelaRosa O, Torre-Cisneros J, Villanueva J, Sanchez B . Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol. 2002; 22(3):176-83. DOI: 10.1023/a:1015476114409. View